Cellseed Inc. logo

Cellseed Inc. (7776)

Market Closed
12 Aug, 06:00
JPX JPX
¥
231. 00
-2
-0.8584%
¥
10.78B Market Cap
- P/E Ratio
- Div Yield
143,700 Volume
- Eps
¥ 233
Previous Close
Add Transaction
Day Range
231 235
Year Range
200 518
Want to track 7776 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

7776 closed today lower at ¥231, a decrease of -0.8584% from yesterday's close, completing a monthly increase of 6.9444% or ¥15. Over the past 12 months, 7776 stock lost -11.1538%.
7776 is not paying dividends to its shareholders.
The last earnings report, released on May 18, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

7776 Chart

People also search for

Fukuda Denshi Co., Ltd.
¥ 12,100
+0.7494%
Pilot Corporation
¥ 1,976.5
-1.446%
Ain Holdings Inc.
¥ 6,015
+0.72%
Union Tool Co.
¥ 16,580
-1.8935%
Osg Corporation
¥ 3,879
-0.3084%

Cellseed Inc. (7776) FAQ

What is the stock price today?

The current price is ¥231.00.

On which exchange is it traded?

Cellseed Inc. is listed on JPX.

What is its stock symbol?

The ticker symbol is 7776.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 10.78B.

Has Cellseed Inc. ever had a stock split?

No, there has never been a stock split.

Cellseed Inc. Profile

Biotechnology Industry
Healthcare Sector
Ms. Setsuko Hashimoto Ph.D. CEO
JPX Exchange
JP3423530009 ISIN
Japan Country
44 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

CellSeed Inc. operates in the forefront of regenerative medicine, focusing on developing innovative cell sheet technologies for various medical applications. Since its inception in 2001, the company has dedicated its efforts to the research, development, and commercialization of groundbreaking cell-sheet regenerative medicine products. These products are aimed at addressing a range of health issues, including esophageal regeneration, knee osteoarthritis, and more. Headquartered in Tokyo, Japan, CellSeed Inc. is at the heart of pioneering health solutions, leveraging cutting-edge science to improve patient outcomes and quality of life.

Products and Services

  • Epithelial Cell Sheet for Esophageal Regeneration

    This product represents a significant advance in treating esophageal diseases by regenerating damaged esophageal tissues using cell sheet technology. It aims to restore normal function and alleviate symptoms for patients suffering from esophageal conditions.

  • Regenerated Cartilage Sheet

    Offering a novel approach to cartilage repair, this regenerated cartilage sheet promotes the healing of damaged cartilage, particularly benefiting individuals with joint issues such as osteoarthritis, by using engineered sheets of chondrocytes to regenerate the affected areas.

  • Chondrocyte Sheet for Knee Osteoarthritis

    Specifically designed for the treatment of knee osteoarthritis, this chondrocyte sheet technology focuses on alleviating pain and improving mobility in patients by repairing the damaged knee cartilage.

  • UpCell

    A temperature-responsive cell cultureware that facilitates the engineering of cell sheets. UpCell represents a pivotal tool in regenerative medicine research, enabling the easy handling and transfer of delicate cell sheets without damage.

  • RepCell

    Another temperature-responsive cell cultureware, RepCell is designed for the efficient collection of cells. This innovation simplifies the process of harvesting cells for further experimentation or therapeutic application.

  • HydroCell

    HydroCell offers a low cell binding cultureware solution, optimizing the conditions for cell growth and maintenance. It is particularly useful in applications where minimal interaction between the cultureware surface and the cells is desired.

  • Peripheral Equipment
    • ThermoPlate III: A heating element made from a transparent glass plate, designed to provide precise temperature control for cell culture, enhancing the quality and consistency of cell sheet production.
    • cellZscope: An automated cell monitoring system that allows for the continuous observation of cell health and behavior, streamlining the research process and providing invaluable insights into cell dynamics.
  • Contract Development and Manufacturing Services

    CellSeed Inc. also extends its expertise through contract development and manufacturing services, offering customizable solutions to meet the specific regenerative medicine needs of its clients. This aspect of the business enables the company to collaborate with partners worldwide, fostering innovation and advancing the field of regenerative medicine.

Contact Information

Address: Telecom Center Building
Phone: 81 3 6380 7490